Загрузка...
Management of the pregnant inflammatory bowel disease patient on antitumour necrosis factor therapy: State of the art and future directions
Antitumour necrosis factor (anti-TNF) therapy has been a major advance in the treatment of inflammatory bowel disease (IBD) by improving rates of mucosal healing, steroid-free remission, and decreasing rates of hospitalization and surgery. Because IBD affects women in their reproductive years, clini...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Pulsus Group Inc
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4205908/ https://ncbi.nlm.nih.gov/pubmed/25101334 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|